|Articles|February 24, 2020
MALDI-DIT Analysis of Modification Site of Chemically Modified Antibody
Author(s)Shimadzu
This application note showcases the high MSn analysis capability of an ultra-compact MALDI digital ion trap (DIT) mass spectrometer, and its ability to obtain information from modified peptides.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5